Suzanne L. Tomchuck, Ph.D.
Affiliations: | 2010 | Biomedical Sciences | Tulane University, New Orleans, LA, United States |
Area:
Cell Biology, Microbiology Biology, ImmunologyGoogle:
"Suzanne Tomchuck"Parents
Sign in to add mentorAline M. Betancourt | grad student | 2010 | Tulane | |
(Suppressor of cytokine signaling proteins regulate toll-like receptor 3 and chemokine receptor signaling in human mesenchymal stem cells.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kreisman NR, Wooliscroft LB, Campbell CF, et al. (2019) Preconditioning Hippocampal Slices with Hypothermia Promotes Rapid Tolerance to Hypoxic Depolarization and Swelling: Mediation by Erythropoietin. Brain Research. 146517 |
Guo XZ, Dash P, Calverley M, et al. (2016) Rapid cloning, expression, and functional characterization of paired αβ and γδ T-cell receptor chains from single-cell analysis. Molecular Therapy. Methods & Clinical Development. 3: 15054 |
Tomchuck SL, Leung WH, Dallas MH. (2015) Enhanced cytotoxic function of natural killer and CD3+CD56+ cells in cord blood after culture. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 39-49 |
Tomchuck SL, He J, Perko RW, et al. (2014) Zoledronic Acid Induces the Proliferation of Human Cord Blood Gamma Delta T Cells Ex Vivo Blood. 124: 1427-1427 |
Tomchuck SL, Henkle SL, Coffelt SB, et al. (2012) Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7 expression in bone marrow-derived human multipotent stromal cells. Plos One. 7: e39592 |
Tomchuck SL, Henkle SL, Coffelt SB, et al. (2012) TLR3 stimulation activates a JAK2/STAT1 pathway in hMSC. Plos One |
Waterman RS, Tomchuck SL, Henkle SL, et al. (2010) A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. Plos One. 5: e10088 |
Coffelt SB, Tomchuck SL, Zwezdaryk KJ, et al. (2009) Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells. Molecular Cancer Research : McR. 7: 907-15 |
Coffelt SB, Marini FC, Watson K, et al. (2009) The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 3806-11 |
Coffelt SB, Waterman RS, Florez L, et al. (2008) Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion. International Journal of Cancer. Journal International Du Cancer. 122: 1030-9 |